Schott Pharma AG KGaA (MIL:1SXP) Total Operating Expense: €146.9 Mil (TTM As of Mar. 2026)


MIL:1SXP Schott Pharma AG & CO KGaA MIL:1SXP
63 GF Score
Price €20.00
GF Value €28.06
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Schott Pharma AG KGaA Total Operating Expense?

Schott Pharma AG KGaA MIL:1SXP +15.34% 63 Total Operating Expense is €146.9 Mil as of Mar. 2026. GuruFocus rates MIL:1SXP with a GF Score™ of 63/100 and a GF Value™ of €28.06 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Schott Pharma AG KGaA's Total Operating Expense for the three months ended in Mar. 2026 was €35.5 Mil. Schott Pharma AG KGaA's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €146.9 Mil.

Schott Pharma AG KGaA Total Operating Expense Related Terms

Schott Pharma AG KGaA Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Schott Pharma AG KGaA's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA Total Operating Expense Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Operating Expense
Get a 7-Day Free Trial 110.92 127.09 145.57 132.65 145.49

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.03 35.98 34.71 40.70 35.55
MIL:1SXP
63GF Score
Schott Pharma AG & CO KGaA MIL:1SXP
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Schott Pharma AG KGaA Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €146.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €146.9 Mil mean?
Schott Pharma AG KGaA (MIL:1SXP) has a Total Operating Expense of €146.9 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Schott Pharma AG KGaA and its competitors.
Is Schott Pharma AG KGaA's Total Operating Expense too high?
Schott Pharma AG KGaA's current Total Operating Expense is €146.9 Mil. Overall, Schott Pharma AG KGaA has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's Total Operating Expense compare to ISRG and BDX?
Schott Pharma AG KGaA's Total Operating Expense of €146.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Schott Pharma AG KGaA and its competitors. Schott Pharma AG KGaA's current Total Operating Expense is €146.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Schott Pharma AG KGaA (MIL:1SXP) is currently considered Modestly Undervalued. The stock's GF Value™ is €28.06, compared to a current price of €20.00 — trading 28.7% below its estimated fair value. The current Total Operating Expense is €146.9 Mil. Schott Pharma AG KGaA's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Schott Pharma AG KGaA (MIL:1SXP), the current Total Operating Expense is €146.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Schott Pharma AG KGaA (MIL:1SXP) Overvalued in 2026?

Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued. The current stock price of €20.00 is trading 28.7% below its estimated GF Value™ of €28.06. GuruFocus considers Schott Pharma AG KGaA to be Modestly Undervalued.

Key valuation signals for MIL:1SXP:

  • Total Operating Expense: €146.9 Mil
  • GF Value™: €28.06 vs. price of €20.00 (28.7% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the MIL:1SXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Schott Pharma AG KGaA Business Description

Other Exchanges 1SXP:Germany1SXP:Austria
Address Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
63GF Score

Get the complete analysis for MIL:1SXP

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.00
Price
€28.06
GF Value